Confirm
News

Company News

Industry News

ToCell "three-in-one" bioreactor redefines upstream productivity!

2021-11-23

The CNBG ToCell "three in one" bioreactor can meet three cultivation processes: full suspension, microcarriers, and sheet-like carriers, to meet your diverse process needs.

View more +

Conference Review丨CNBG ToCell invites you to review the highlights of the 21st China Biologics Annual Conference (CBioPC2021)!

2021-10-19

Having in-depth face-to-face interaction and communication with industry elites from all over the country is our most valuable gain.

View more +

Conference Review丨ToCell made a wonderful appearance at the BIC2021 3rd Asian Biopharmaceutical Innovation Summit!

2021-09-30

CNBG ToCell showcased its core products - personalized cell culture media, bioreactors, and a new product - Cellcomb carrier - at this conference, discussing industry prospects and cooperation opportunities with numerous industry professionals.

View more +

New product release! ToCell's localized paper carrier - Cellcomb carrier is launched!

2021-08-24

The Cellcomb carrier, a domestically produced paper carrier with complete independent intellectual property rights and fully localized raw materials, key technologies, and core processes, has been launched!

View more +

Strive for the new century and embark on a new journey - warmly celebrate the 100th anniversary of the founding of the Communist Party of China!

2021-07-01

Striving to create history and working hard to achieve the future, CNBG ToCell people are full of glorious dreams, shouldering mission responsibilities, and embarking on a new journey of high-quality development with an unyielding attitude!

View more +

The China Vaccine Industry Association issued a notice to commend ToCell Bio for its outstanding performance in anti-epidemic work!

2021-06-04

Recently, the China Vaccine Industry Association issued a decision to commend outstanding collectives and individuals (second batch) in the fight against the epidemic

View more +

ToCell Biological Culture Medium Production Department was awarded the honorary title of "Sinopharm Group's Advanced Collective in Fighting the COVID-19 Epidemic"!

2021-05-18

Because of its outstanding performance in the fight against the COVID-19, CNBG ToCell (Wuxi) Biotechnology Co., Ltd., The Culture Media Production Department was awarded the honorary title of "Advanced Collective of Sinopharm

View more +

Win-win cooperation丨Nanjing Agricultural University ToCell Biopharmaceutical Process Technology Research Institute was established!

2021-04-16

On the afternoon of April 15, ToCell (Suzhou) Biotechnology Co., Ltd. (hereinafter referred to as "ToCell"), a subsidiary of China Biologic, and Nanjing Agricultural University held a signing ceremony for industry-university-research

View more +

Sinopharm Group CNBG's inactivated COVID-19 vaccine has been approved for conditional marketing!

2020-12-31

At 10:00 on December 31, the Joint Prevention and Control Mechanism of the State Council held a press conference to announce that the inactivated COVID-19 vaccine of Sinopharm Group China National Biotec Group

View more +

A delegation of Chinese biological experts visited the Lanzhou Biological Pharmaceutical Factory of China Animal Husbandry Industry Co., Ltd. to inspect the ToCell bioreactor project

2020-11-27

On November 25, Vice President Li Xiangrong and Vice President Yang Huichuan of China National Biotec Group led a strong team of experts from Beijing Institute of Biological Products Co., Ltd.,

View more +
<
1 2 3
>